We examined the HIV-inhibitory effects previously found to be associated wi
th scrub typhus infection. Individual 500 nil units of plasma from donors w
ith mild scrub typhus were safety-tested, subjected to virucidal heat treat
ment, and administered to 10 HIV-1-infected recipients who were not receivi
ng antiretroviral drugs. HIV-1 copy number fell threefold or more in two re
cipients, and virus burden was reduced for 8 weeks in 70% (7/10) of recipie
nts of a single plasma infusion, compared with the mean of three pre-infusi
on measurements. Scrub typhus donor plasma inhibited HIV-1 in vitro compare
d with normal human plasma and media controls. in the clearest in vivo resp
onse, reduction in viral load was accompanied by clinical improvement, a sw
itchback from the syncytia-inducing to the non-syncytia-inducing phenotype,
and decreases in CD8 cells and IL-6 levels. Scrub typhus infections can ge
nerate heat-stable, transferable plasma factors that exert prolonged anti-H
IV effects. Whether variability in the results is due to different scrub ty
phus infections, different HIV infections or different individual responses
, is unclear.